Tim Smeets

Tim Smeets serves as a Researcher in the Pharmacy department at Erasmus MC, focusing on clinical pharmacology within critical care settings. His work bridges pharmaceutical sciences and intensive care medicine, with particular emphasis on optimizing drug therapy for critically ill patients requiring renal replacement therapies.

His research profile reveals deep expertise in pharmacokinetics of antibiotics and sedatives in organ failure states. Key interests include:

• Vancomycin and fluconazole dosing in continuous renal replacement therapy
• Drug-drug interactions involving CFTR modulators and antifungals
• Augmented renal clearance phenomena in sepsis and trauma
• Midazolam metabolism during CRRT in viral pneumonias

His fingerprint shows dominant activity in Pharmacokinetics (49%), Vancomycin research (100%), and Continuous Renal Replacement Therapy (37%).

His recent publications demonstrate significant contributions to critical care pharmacology through high-impact journals like Journal of Critical Care and Blood Purification. Work spans therapeutic drug monitoring challenges in hemodialysis, antibiotic optimization in sepsis, and novel drug interactions in cystic fibrosis patients.

While no formal awards are listed in the current profile, his research has garnered attention through news pickups, social media discussions (including 4 X posts), and substantial academic engagement (over 50 Mendeley readers across publications).

His collaborative network spans multiple Erasmus MC departments including Critical Care Medicine and Pulmonology, with strong clinical pharmacy integration. Current work appears focused on precision dosing strategies for renally cleared medications in complex ICU scenarios, particularly investigating variable drug clearance during extracorporeal therapies.